ProShare Advisors’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$923K Sell
18,898
-1,149
-6% -$56.1K ﹤0.01% 851
2025
Q1
$1.02M Sell
20,047
-5,055
-20% -$258K ﹤0.01% 806
2024
Q4
$1.13M Buy
25,102
+6,164
+33% +$278K ﹤0.01% 861
2024
Q3
$703K Buy
18,938
+4,551
+32% +$169K ﹤0.01% 944
2024
Q2
$440K Sell
14,387
-3,926
-21% -$120K ﹤0.01% 1047
2024
Q1
$533K Buy
18,313
+1,564
+9% +$45.5K ﹤0.01% 1041
2023
Q4
$462K Buy
16,749
+2,616
+19% +$72.1K ﹤0.01% 1087
2023
Q3
$317K Buy
14,133
+119
+0.8% +$2.67K ﹤0.01% 1176
2023
Q2
$570K Buy
14,014
+629
+5% +$25.6K ﹤0.01% 895
2023
Q1
$648K Sell
13,385
-1,599
-11% -$77.5K ﹤0.01% 823
2022
Q4
$572K Buy
14,984
+1,221
+9% +$46.6K ﹤0.01% 901
2022
Q3
$691K Buy
13,763
+314
+2% +$15.8K ﹤0.01% 803
2022
Q2
$539K Sell
13,449
-6,959
-34% -$279K ﹤0.01% 917
2022
Q1
$762K Sell
20,408
-4,721
-19% -$176K ﹤0.01% 1038
2021
Q4
$1M Buy
25,129
+1,140
+5% +$45.4K ﹤0.01% 1016
2021
Q3
$893K Sell
23,989
-6,689
-22% -$249K ﹤0.01% 942
2021
Q2
$1.3M Buy
30,678
+4,440
+17% +$188K ﹤0.01% 892
2021
Q1
$1.24M Buy
26,238
+2,020
+8% +$95.6K ﹤0.01% 875
2020
Q4
$1.48M Buy
24,218
+5,731
+31% +$350K 0.01% 726
2020
Q3
$864K Buy
18,487
+41
+0.2% +$1.92K ﹤0.01% 766
2020
Q2
$936K Buy
18,446
+6,413
+53% +$325K 0.01% 731
2020
Q1
$537K Sell
12,033
-9,484
-44% -$423K ﹤0.01% 721
2019
Q4
$1.03M Sell
21,517
-958
-4% -$46K ﹤0.01% 789
2019
Q3
$760K Sell
22,475
-36
-0.2% -$1.22K ﹤0.01% 847
2019
Q2
$1.01M Sell
22,511
-2,556
-10% -$115K 0.01% 750
2019
Q1
$944K Buy
25,067
+3,213
+15% +$121K 0.01% 783
2018
Q4
$750K Sell
21,854
-4,180
-16% -$143K 0.01% 795
2018
Q3
$1.22M Buy
26,034
+550
+2% +$25.9K 0.01% 739
2018
Q2
$860K Buy
25,484
+1,177
+5% +$39.7K 0.01% 888
2018
Q1
$658K Sell
24,307
-3,999
-14% -$108K ﹤0.01% 987
2017
Q4
$472K Buy
28,306
+2,237
+9% +$37.3K ﹤0.01% 1162
2017
Q3
$522K Buy
26,069
+1,954
+8% +$39.1K ﹤0.01% 946
2017
Q2
$442K Buy
24,115
+1,970
+9% +$36.1K ﹤0.01% 1000
2017
Q1
$218K Sell
22,145
-5,870
-21% -$57.8K ﹤0.01% 1410
2016
Q4
$306K Buy
28,015
+3,129
+13% +$34.2K ﹤0.01% 1349
2016
Q3
$349K Sell
24,886
-4,687
-16% -$65.7K ﹤0.01% 1093
2016
Q2
$208K Buy
29,573
+243
+0.8% +$1.71K ﹤0.01% 1399
2016
Q1
$189K Sell
29,330
-3,160
-10% -$20.4K ﹤0.01% 1436
2015
Q4
$1.05M Buy
32,490
+3,122
+11% +$101K 0.01% 713
2015
Q3
$784K Sell
29,368
-1,949
-6% -$52K 0.01% 760
2015
Q2
$1.51M Sell
31,317
-474
-1% -$22.8K 0.02% 608
2015
Q1
$1.93M Buy
31,791
+4,304
+16% +$262K 0.02% 571
2014
Q4
$1.42M Buy
27,487
+3,183
+13% +$165K 0.02% 691
2014
Q3
$1.07M Sell
24,304
-4,759
-16% -$210K 0.01% 1050
2014
Q2
$760K Sell
29,063
-4,925
-14% -$129K 0.01% 1318
2014
Q1
$888K Buy
33,988
+22,344
+192% +$584K 0.01% 1400
2013
Q4
$198K Buy
+11,644
New +$198K ﹤0.01% 1259